Unusual Cause for Continuous Renal Replacement Therapy Filter Clotting.
作者信息
Whitlow Michael, Rajasekaran Arun, Rizk Dana
机构信息
Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
出版信息
Kidney360. 2020 Mar 6;1(3):225-226. doi: 10.34067/KID.0000092019. eCollection 2020 Mar 26.
Abstract
摘要
相似文献
1
Unusual Cause for Continuous Renal Replacement Therapy Filter Clotting.持续肾脏替代治疗滤器凝血的罕见原因
Kidney360. 2020 Mar 6;1(3):225-226. doi: 10.34067/KID.0000092019. eCollection 2020 Mar 26.
2
Filter clotting with continuous renal replacement therapy in COVID-19.COVID-19中连续性肾脏替代疗法的滤器凝血
J Thromb Thrombolysis. 2021 May;51(4):966-970. doi: 10.1007/s11239-020-02301-6. Epub 2020 Oct 7.
3
Revisiting Filtration Fraction as an Index of the Risk of Hemofilter Clotting in Continuous Venovenous Hemofiltration.重新审视滤过分数作为连续性静脉-静脉血液滤过中血液滤过器凝血风险指标的意义。
Clin J Am Soc Nephrol. 2020 Nov 6;15(11):1660-1662. doi: 10.2215/CJN.02410220. Epub 2020 May 13.
4
Continuous Renal Replacement Therapy Without Anticoagulation: Top Ten Tips to Prevent Clotting.连续肾脏替代治疗无抗凝：预防血栓形成的十大技巧。
Blood Purif. 2020;49(4):490-495. doi: 10.1159/000505260. Epub 2020 Jan 7.
5
Filter life and safety of heparin-grafted membrane for continuous renal replacement therapy - A randomized controlled trial.肝素接枝膜用于连续性肾脏替代治疗的滤过寿命和安全性 - 一项随机对照试验。
Semin Dial. 2021 Jul;34(4):300-308. doi: 10.1111/sdi.12951. Epub 2021 Feb 8.
6
CKRT Clotting and Cerebrovascular Accident in a Critically Ill Patient.危重症患者的连续性肾脏替代治疗中的凝血与脑血管意外
Kidney360. 2020 Jul 20;1(7):718-719. doi: 10.34067/KID.0003112020. eCollection 2020 Jul 30.
7
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.局部枸橼酸抗凝与全身肝素抗凝对连续性肾脏替代治疗中急性肾损伤危重症患者透析滤器寿命和死亡率的影响：一项随机临床试验。
JAMA. 2020 Oct 27;324(16):1629-1639. doi: 10.1001/jama.2020.18618.
8
Review of Anticoagulation in Continuous Renal Replacement Therapy.连续肾脏替代治疗中的抗凝治疗综述。
Crit Care Nurs Q. 2022;45(2):144-155. doi: 10.1097/CNQ.0000000000000397.
9
Association between Intra-Circuit Activated Clotting Time and Incidence of Bleeding Complications during Continuous Renal Replacement Therapy using Nafamostat Mesilate: a Retrospective Pilot Observational Study.使用甲磺酸萘莫司他进行连续性肾脏替代治疗期间回路内活化凝血时间与出血并发症发生率之间的关联：一项回顾性初步观察研究。
Kobe J Med Sci. 2017 Aug 30;63(1):E30-E36.
10
Continuous renal replacement therapy without anticoagulation in critically ill patients at high risk of bleeding: A systematic review and meta-analysis.危重症出血高风险患者无抗凝连续肾脏替代治疗：系统评价和荟萃分析。
Semin Dial. 2021 May;34(3):196-208. doi: 10.1111/sdi.12946. Epub 2021 Jan 5.
引用本文的文献
1
Metabolic disturbances potentially attributable to clogging during continuous renal replacement therapy.在持续肾脏替代治疗期间，代谢紊乱可能归因于管路堵塞。
Intensive Care Med Exp. 2023 Dec 21;11(1):99. doi: 10.1186/s40635-023-00581-9.
本文引用的文献
1
Propofol and Clevidipine-induced Hypertriglyceridemia.丙泊酚和左西孟旦引起的高甘油三酯血症。
不过你原文中“Clevidipine”有误，正确的应该是“Levosimendan”，按照正确的来翻译是：丙泊酚和左西孟旦引起的高甘油三酯血症。
Cureus. 2018 Aug 20;10(8):e3165. doi: 10.7759/cureus.3165.
2
Hypertriglyceridemia Causing Continuous Renal Replacement Therapy Dysfunction in a Patient with End-stage Liver Disease.终末期肝病患者中高甘油三酯血症导致持续肾脏替代治疗功能障碍
Indian J Nephrol. 2018 Jul-Aug;28(4):303-306. doi: 10.4103/ijn.IJN_201_17.
3
Propofol infusion syndrome in adults: a clinical update.成人丙泊酚输注综合征：临床最新进展
Crit Care Res Pract. 2015;2015:260385. doi: 10.1155/2015/260385. Epub 2015 Apr 12.
4
Propofol infusion syndrome.丙泊酚输注综合征
Anaesthesia. 2007 Jul;62(7):690-701. doi: 10.1111/j.1365-2044.2007.05055.x.
Zotero 插件